Our Scientific Focus
Leveraging the symbiosis between the immune system and the microbiome to improve cancer patients' lives
Five-year impact focus
There are several known microbiome modifiers that may impact how a patient responds to cancer immunotherapy. To quickly deliver better outcomes for patients, Seerave will focus on modifiers where the opportunity to change clinical care is most practical, and where robust scientific data best supports translation.
Beginning with antibiotics, Seerave aims to clarify how their use impacts patient outcomes, inform practical advice for clinicians and patients, and propel the development of new tools and technologies with the potential to significantly improve patients’ lives in the next five years.
The Theory of Change
Guided by our Theory of Change, our mission is to improve patient outcomes through four strategic pillars
Data Integration
Build a data consortium that collaboratively integrates and interrogates clinical data on microbiome modifiers in cancer immunotherapy from leading hospitals and research institutions.
Policy & Practice
Empower oncologists and other key stakeholders with practical, evidence-based advice that reflects the latest understanding of the role of microbiome modifiers in cancer care.
Novel Tools
Foster the development of new tools and services for oncologists through Seerave Ventures, our hands-on impact investment vehicle that supports a select number of mission-aligned companies with the potential to transform patient care.
Community & Collaboration
Cultivate community across disciplinary silos and geography by creating and empowering a self-sustained, mission-aligned network of relevant stakeholders, including clinical researchers, clinical practitioners, public health experts, entrepreneurs, and patient advocates.
Impact from Bench to Bedside
Step by step, we are aiming for impact
Despite being a small family foundation that has been operational only since 2017, we are proud of the network we have built, the collaborations we have established, and the impact we have generated.
350+
Patients Impacted
18
Scientific Studies
33
Publications
81
Collaborations
17
Seerave Fellows
14
Research Institutes
7
Translational Initiatives
10+
Impact Investments